A Clinical Study of GZR33 and GZR101 in Healthy Subjects

NCT06556641 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

28

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Subjects

Interventions

DRUG: GZR33 Injection
DRUG: GZR101 Injection
DRUG: Placebo
DRUG: Insulin Degludec

Sponsor

Gan and Lee Pharmaceuticals, USA